Tagged nasdaq-regn
Press Release
NASDAQ:REGN Lawsuit Notice: Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Should Contact the Shareholders Foundation
A lawsuit was filed for certain investors in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares. Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and continue to hold any of those NASDAQ:REGN shares, should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
Press Release
Investors Who Hold Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Should Contact the Shareholders Foundation in Connection With Lawsuit
A lawsuit was filed for certain investors in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares. Investors in NASDAQ: REGN shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More